The Regulatory Capacity of Bivalent Genes-A Theoretical Approach

International Journal of Molecular Sciences
Torsten ThalheimJoerg Galle

Abstract

Bivalent genes are frequently associated with developmental and lineage specification processes. Resolving their bivalency enables fast changes in their expression, which potentially can trigger cell fate decisions. Here, we provide a theoretical model of bivalency that allows for predictions on the occurrence, stability and regulatory capacity of this prominent modification state. We suggest that bivalency enables balanced gene expression heterogeneity that constitutes a prerequisite of robust lineage priming in somatic stem cells. Moreover, we demonstrate that interactions between the histone and DNA methylation machineries together with the proliferation activity control the stability of the bivalent state and can turn it into an unmodified state. We suggest that deregulation of these interactions underlies cell transformation processes as associated with acute myeloid leukemia (AML) and provide a model of AML blast formation following deregulation of the Ten-eleven Translocation (TET) pathway.

References

Jan 5, 2000·DNA and Cell Biology·L Amaravadi, M J Klemsz
Aug 30, 2003·Immunologic Research·Meixia Zhou, Wenjun Ouyang
Mar 16, 2005·Molecular and Cellular Biology·Yutaka OkunoDaniel G Tenen
Dec 17, 2005·Nature·Emmanuelle ViréFrançois Fuks
May 19, 2007·Nature Reviews. Genetics·Uri Alon
Jul 21, 2007·Proceedings of the National Academy of Sciences of the United States of America·Joanne L AttemaIrving L Weissman
May 9, 2008·Cell Stem Cell·Sol EfroniEran Meshorer
Sep 1, 2009·Epigenetics : Official Journal of the DNA Methylation Society·Margaret RushMatthew C Lorincz
Oct 6, 2009·Nature Genetics·Ann-Marie BröskeFrank Rosenbauer
Mar 12, 2010·Genome Research·Vardhman K RakyanTimothy D Spector
Mar 31, 2011·Cold Spring Harbor Symposia on Quantitative Biology·S Buratowski, T Kim
May 18, 2011·Current Opinion in Hematology·Rita Shaknovich, Ari Melnick
May 30, 2012·Nature Reviews. Genetics·Peter A Jones
Jun 13, 2012·Cytotherapy·Sébastien AnguilleZwi N Berneman
Aug 24, 2012·PLoS Computational Biology·Kim Sneppen, Ian B Dodd
Oct 2, 2012·Cell·Philipp VoigtDanny Reinberg
Oct 16, 2012·Proceedings of the National Academy of Sciences of the United States of America·Roy D DarLeor S Weinberger
Feb 28, 2013·Development·Marissa Morales Del Real, Ellen V Rothenberg
Mar 21, 2013·BMC Genomics·Brian J AbrahamKeji Zhao
May 3, 2013·The New England Journal of Medicine·UNKNOWN Cancer Genome Atlas Research NetworkGreg Eley
Nov 14, 2013·PloS One·Wai Lim KuEdward Ott
Dec 25, 2013·Nature Reviews. Genetics·Taiping Chen, Sharon Y R Dent
Jun 20, 2014·Genome Medicine·Miriam SonnetChristoph Plass
Aug 6, 2014·Proceedings of the National Academy of Sciences of the United States of America·Philip JermannDirk Schübeler
Nov 20, 2014·Epigenetics & Chromatin·Lisette C M Anink-GroenenFrank J Bruggeman
Mar 21, 2015·Genes & Development·Constance AlabertAnja Groth
Oct 18, 2015·EMBO Reports·Tianyi ZhangNeil Brockdorff

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry
fluorescence-activated cell sorting

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Experimental Hematology
Aniket V Gore, Brant M Weinstein
Cold Spring Harbor Perspectives in Medicine
Robert L Bowman, Ross L Levine
Genes & Development
Philipp VoigtDanny Reinberg
© 2022 Meta ULC. All rights reserved